Brandon Pang

Brandon Pang

Auto-generated profile, based on publicly available information

Brandon Pang

Boston University School of Medicine Boston, Massachusetts

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
APAnna J. Podolanczuk
Anna J. Podolanczuk
GHGary M. Hunninghake
Gary M. Hunninghake
KWKevin C. Wilson
Kevin C. Wilson
YKYet H. Khor
Yet H. Khor
FKFayez Kheir
Fayez Kheir
CRChristopher J. Ryerson
Christopher J. Ryerson
Background: There is growing interest in identifying early stages of interstitial lung disease (ILD) to improve patient outcomes. This document reviews updated evidence on interstitial lung abnormalities (ILAs); provides suggestions for screening, evaluation, and management; proposes criteria for distinguishing ILAs from ILD; and identifies research priorities. Methods: A committee of clinical and methodology experts met by video conference to define ILAs and ILD by consensus and voted on 11 prespecified questions after reviewing synthesized evidence from a systematic literature search. Agreement of ≥70% was required to approve each suggestion. Results: ILA is defined as nondependent bilateral parenchymal abnormalities on computed tomography, including ground-glass opacities or reticulations, lung distortion, traction bronchiectasis, and/or honeycombing involving ≥5% of a lung zone. The updated definition removes the prior exclusion of high-risk populations. ILD is distinguished from ILAs by symptoms (dyspnea/cough) attributable to an interstitial process, abnormal or declining lung function, fibrotic (honeycombing and/or reticulation with traction bronchiectasis involving ≥5% of total lung volume) or progressive imaging abnormalities, and/or specific fibrotic ILD patterns on imaging or pathology. Suggestions include ILA/ILD assessment on imaging acquired for lung cancer screening, screening adults with connective tissue disease and first-degree relatives of patients with familial pulmonary fibrosis, assessing baseline symptoms and pulmonary function among those with ILAs, and monitoring ILAs with chest computed tomography every 2–3 years. Conclusions: This document presents a comprehensive literature review of ILAs with updates to the Fleischner Society ILA definition, establishes a working ILD definition, and provides evidence-based suggestions for ILA evaluation and management.

1 June 2023 in Annals of the American Thoracic Society
Verified
Journal Article
Closed access
BPBrandon Pang
Brandon Pang
LKLauren Kearney
Lauren Kearney
JMJennifer Maccarone
Jennifer Maccarone
JZJingzhou Zhang
Jingzhou Zhang
CKChristopher Kearney
Christopher Kearney
NBNicholas A. Bosch
Nicholas A. Bosch

6 September 2024 in CHEST Critical Care
Verified
Journal Article
Open access
CKChristopher Kearney
Christopher Kearney
BBBrooke Barlow
Brooke Barlow
BPBrandon Pang
Brandon Pang
NBNicholas A. Bosch
Nicholas A. Bosch

1 April 2025 in Annals of the American Thoracic Society
Verified
Journal Article
Closed access
BPBrandon Pang
Brandon Pang
CKChristopher M. Kearney
Christopher M. Kearney
ALAnica C. Law
Anica C. Law
NBNicholas A. Bosch
Nicholas A. Bosch

22 June 2024 in CHEST Critical Care
Verified
Journal Article
Open access
BSBurton H. Shen
Burton H. Shen
ADAaron C. Dobie
Aaron C. Dobie
SSSara L. Shusterman
Sara L. Shusterman
MDMine Duzgol
Mine Duzgol
CHCollin Homer-Bouthiette
Collin Homer-Bouthiette
ALAnica C. Law
Anica C. Law
More than 90,000 children and adults in the United States are hospitalized with an asthma exacerbation annually, and between 5% and 34% of these hospitalizations include admission to an ICU. It is unclear how adolescent and young adults with severe asthma exacerbations are triaged in the inpatient setting between PICUs and adult ICUs. Using a large multicenter US cohort, we characterized how hospitals triage adolescents and young adults with asthma exacerbations between PICUs and adult ICUs. How do hospitals across the United States triage adolescents and young adults with asthma exacerbations between PICUs and adult ICUs? This was a retrospective cohort study carried out from 2016 through 2022 using the enhanced-claims PINC AI database. Participants were patients aged 12 to 26 years who were hospitalized with an asthma exacerbation and admitted to a PICU or adult ICU. We used nested hierarchical multivariable regression models to quantify changes in the intraclass correlation coefficient (ICC; a measure of variation in triage decisions attributable to hospital of admission after accounting for covariables). Analyses included 3,946 admissions from 93 hospitals. Stratified by age, the percent of patients admitted to PICUs dropped by 26.9% between 17 and 18 years of age. In the nested models, the ICC showed a large decrease going from the empty model (28.7%) to the age-adjusted model (4.5%), but was similar between the age-adjusted and fully adjusted model (3.4%). Our results showed that among adolescents and young adults with asthma exacerbations, age of 18 years or younger was a strong determinant of PICU triage. Further research is needed to understand differences in asthma care and outcomes between PICUs and adult ICUs, as well as how intermediate care units affect triage decision-making from wards and the ED.